Abstract
Four highly oxidized pimarane diterpenoids were isolated from Kaempferia takensis rhizomes. Kaemtakols A–C possess a tetracyclic ring with either a fused tetrahydropyran or tetrahydrofuran motif. Kaemtakol D has an unusual rearranged A/B ring spiro-bridged pimarane framework with a C-10 spirocyclic junction and an adjacent 1-methyltricyclo[3.2.1.02,7]octene ring. Structural characterization was achieved using spectroscopic analysis, DP4 + and ECD calculations, as well as X-ray crystallography, and their putative biosynthetic pathways have been proposed. Kaemtakol B showed significant potency in inhibiting nitric oxide production with an IC50 value of 0.69 μM. Molecular docking provided some perspectives on the action of kaemtakol B on iNOS protein.
Graphical Abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
The genus Kaempferia is a member of the Zingiberaceae family, encompassing over 60 species. This genus exhibits a broad distribution across Southeast Asia, with a significant presence in Thailand [1, 2]. The rhizomes of Kaempferia plants are rich in isopimarane, abietane, labdane, and clerodane type diterpenoids [3,4,5,6]. Additionally, some intriguing rearranged diterpenoids have been identified, such as unique norditerpenoids featuring an epoxide bridge with a hemiketal ring named elegansins D and E, from K. elegans [7].
Compounds isolated from Kaempferia species have gained attention due to their wide array of structural variations and remarkable anti-inflammatory effects [8,9,10,11]. Nonetheless, the scientific exploration concerning chemical characterization and biological studies has been confined to only a handful of species, such as K. parvifera, K. galanga, K. marginata, and K. pulchra [1]. As a result, research on plants in this genus, essentially those unexplored, could potentially unveil novel diterpenoids with intriguing structural frameworks and promising biological properties.
Here, we investigated the chemical constituents from K. takensis Boonma & Saensouk, which to date have not yet been reported. Our investigation led to the isolation of the architecturally unique highly oxidized pimarane diterpenoids, kaemtakols A–D (1–4, Fig. 1). Compounds 1–3 were characterized as C-20 oxygenated methylene pimarane-type diterpenoids with either a fused tetrahydropyran or tetrahydrofuran ring. Compound 4 featured an unusual rearranged A/B ring spiro-bridged pimarane framework with the presence of a rare spiro[5,5]decane moiety adjacent to a 1-methyltricyclo[3.2.1.02,7]octene ring. All compounds were examined for their ability to reduce inflammation, by suppressing nitric oxide (NO) generation in RAW264.7 macrophage cells and by inhibiting NF-κB production in HaCat human skin cells.
2 Results and discussion
Kaemtakol A (1), colorless crystals, has a molecular formula C24H34O7, deduced from the HRESIMS [M + Na]+ at m/z 457.2204 and supported by 13C and DEPT 135 NMR data, suggesting eight unsaturation indices. The IR absorption peaks at 3415 cm–1 and 1740 cm–1 indicated hydroxy and ester functional groups. The 1H- NMR (Table 1) exhibited signals for three quaternary methyls δH/δC 1.09/25.4 (CH3-17), 1.37/22.6 (CH3-18), and 1.08/34.5 (CH3-19); two acetyl methyls at δH 2.12 and 2.22; an oxymethylene group at δH/δC 3.53 and 3.96 (each 1H, d, J = 10.4 Hz)/65.8; two oxymethine groups at δH/δC 4.78/71.9 and 5.64/71.7; a vinyl group with the δH values of 4.98 (1H, d, J = 10.6 Hz), 5.04 (1H, d, J = 17.6 Hz), and 5.86 (1H, dd, J = 17.5, 10.6 Hz); and an olefinic proton at δH/δC 5.95/132.9. The 13C-NMR and DEPT of compound 1 presented twenty-four carbon signals, which matched with five methyl carbons including two acetyl methyls, six methylene carbons including one alkene and one oxygenated, five methine carbons including two oxymethines and two olefinics, and eight quaternary carbons including one alkene, two carbonyls, one oxygenated, and one hemiketal (Table 1). Excluding the above four degrees of unsaturation from two double bonds and two carbonyls, the remaining four unsaturation indices implied a tetracyclic compound. Hence, the structure of 1 was identified as C-20 oxygenated methylene pimarane diterpenoid, featuring a tetracyclic ring bearing two acetoxy groups. The COSY correlations of four spin systems comprising H-1/H2-2/H2-3, H-5/H-6, H2-11/H2-12, and H-15/H2-16, together with the HMBC correlations connecting H3-18 and H3-19 to C-3, C-4, and C-5; H2-20 to C-1, C-5, C-7, and C-9; H-1 to C-3, C-5, and C-20; H-5 to C-6, C-10, C-18, C-19, and C-20; H-14 to C-7, C-9, C-13, C-15, and C-17; and H3-17 to C-12 and C-14, suggested the structural architecture of 1 (Fig. 2). Based on the NOESY experiment, it was indicated that rings A and B displayed a trans-decalin, with the α-axial hydrogen on C-5 and a β-axial position of C-20. Additionally, the acetoxy group on C-1 was found to be in an α-axial position, and the oxygen linkage connecting C-7 and C-20 was situated above the B-ring plane. The C-6 relative configuration was assigned by a large coupling constant value of 3J5,6 (\(\approx\) 10 Hz) which implied that the dihedral angle between them was nearly 0 degree, indicating a cis relationship [12]. This relationship was further proved by the presence of H-5 and H-6 with H3-19 correlations, and the absence of correlation of either H3-18 or H2-20 in the NOESY spectrum (Fig. 2). Thus, these above observations revealed the β-equatorial position of the OAc group on C-6. The X-ray crystallography analysis supported the assigned conformation of 1 and the visual representation of the crystal structure provided by ORTEP drawing is depicted (Fig. 3). Consequently, 1 was structurally determined as 7α,9α-dihydroxy-1α,6β-diacetoxy-7β,20-epoxyisopimara-8(14),15-diene. Furthermore, based on the high resemblance between the calculated and measured ECD spectrum, the (1S,5S,6S,7R,9S,10S,13R) absolute configuration of 1 was determined (Fig. 4).
A white amorphous compound 2 named kaemtakol B was formulated as C22H32O6 by HRESIMS at m/z of 415.2099 [M + Na]+. NMR analysis revealed that compounds 1 and 2 were C-20 oxygenated methylene pimarane-type diterpenoids bearing an epoxide ring (Table 1). Their NMR data closely resembled each other, with the only difference being the presence of a secondary alcohol on C-1 in 2. This alcohol at C-1 (δC 67.8) position was confirmed using HMBC cross-peaks that connected H-1 (δH 3.77) to C-5, and H2-20 to C-1 and C-5. Additionally, an oxygen linkage connecting C-7 and C-20 resembling that of 1 could be established from HMBC cross-peaks connecting H-1 and H-5 to C-20; and H-5, H-14, and H2-20 to C-7. The above analyses enabled the establishment of the 2D structure of 2. The NOESY experiment (Fig. 2) unveiled an identical trans-decalin A/B ring pattern to 1, with the hydroxy group on C-1 occupying an α-equatorial position, the 7,20-oxygen bridge situated above the B-ring plane, HO-7 positioned in an α-orientation, and H2-20 in part of the 7,20-oxygen bridge located in a β-orientation. Consequently, 2 was structurally determined as 1α,7α,9α-trihydroxy-6β-acetoxy-7β,20-epoxyisopimara-8(14),15-diene. The high resemblance between the calculated and measured ECD spectra of 2 strongly suggested the (1S, 5S, 6S, 7R, 9S, 10S, 13R) absolute configuration (Fig. 4).
The 1D-NMR spectra of kaemtakol D (3) suggested the presence of a C-20 oxygenated methylene pimarane diterpenoid, and its structure appeared to resemble that of 2 (Table 1). The main differences were detected in the placement of the C-6 hemiketal hydroxy group at δC 107.3 and the C-7 acetoxy group at δC 78.1. These differences were confirmed through HMBC cross-peaks connecting H-5 and H2-20 to C-6, and H-5 and H-14 to C-7 (Fig. 2). NOESY interactions and the optimized structure obtained from the conformer analysis were used to determine compound 3 relative configuration (Fig. 2), which suggested the trans-decalin arrangement of the A/B rings having H-5 positioned in an α-axial orientation and C-20 in an β-axial orientation. As a consequence, the β-oriented acetoxy group at C-7, the α-oriented hydroxy group at C-1, and the oxygen linkage connecting C-6 and C-20 above the B-ring plane were assigned. Hence, compound 3 was determined to be 1α,6α,9α-trihydroxy-7β-acetoxy-6β,20-epoxyisopimara-8(14),15-diene. The high resemblance between the calculated and measured ECD spectra of 3 established the (1S, 5S, 6S, 7R, 9R, 10S, 13R) absolute configuration (Fig. 4).
Kaemtakol D (4) presented a molecular formula C22H28O5, deduced from the HRESIMS ion at m/z 395.1827 [M + Na]+, consistent with nine unsaturation indices. The IR absorption peaks at 3352, 1732, and 1714 cm–1 suggested hydroxy and carbonyl functional groups. The 13C-NMR data revealed twenty-two carbon signals as the resonances of four singlet methyls (one of which being an acetoxy), five methylenes (one of which being an oxymethylene carbon), six methines (including one oxymethine carbon and one sp2 hybridized aldehyde carbon), and seven quaternary carbons (including one olefinic carbon and two sp2 hybridized carbonyls). The abovementioned functional groups attributed to four out of the nine degrees of unsaturation, leaving five degrees to be deduced as a pentacyclic ring. The 1H-NMR spectrum exhibited four methyl protons at δH 2.05 (an acetyl group), 1.32, 1.28, and 1.05, oxymethylene protons at δH 4.83 and 4.59, an oxymethine proton at δH 5.13, as well as an aldehyde proton at δH 9.93 (Table 1). The COSY spin systems led to the assignment of three fragments: H-1/H2-2/H2-3 for C-1 to C-3, H-5/CHO for C-5 with an aldehyde function, and H-14/H-15/H2-16/H-11/H2-12 for C-11 to C-16 (Fig. 2). By deduction from HMBC correlations (Fig. 2), these fragments expanded to form the major portion of the molecules. Furthermore, the HMBC correlations were used to establish the bond connections between rings A and B, whereby the observed cross-peaks from H-5 to C-1 (δC 73.8), C-6 (δC 202.9, an aldehyde group), C-10, C-20 (δC 69.7), and a gem-dimethyl group, from H-6 to C-5, from a gem-dimethyl group to C-3 and C-5, and from H2-20 to C-1, C-5, C-7 (δC 163.7, an ester carbonyl group), C-9 (δC 154.6, an alkene group), and C-10, indicated the appearance of a six-membered carbocycle (A) with a geminal dimethyl group at C-4, an aldehyde unit at C-5, a lactone ring (B), two oxygen atoms (at C-1 and C-20), along with two quaternary carbons (at C-4, and C-10). Therefore, rings A and B are united by a bridged spiro lactone moiety. The incorporation of the remaining tricyclo unit to complete a pentacyclic structure was guided by the HMBC cross-peaks connecting H-11 to C-8 and C-13, H2-12 to C-9, and H-14 to C-9 and C-17 (Fig. 2). In addition, an isolated methylene unit that displayed an AB geminal coupling pattern of H2-16 (δH 1.54 and 0.53) was assigned to be at the junction between C-11 and C-13, and this position was further verified by long-range correlations between H-11 and C-15, H2-16 and C-9, H2-16 and C-12, as well as H3-17 and C-14 and C-15. Moreover, the cross-peaks from H-14 to C-7 (δC 163.7) signified the incorporation of the carbonyl carbon into the lactone ring, thereby necessitating the linkage of C-7 to C-8. The last remaining assignment of carbonyl carbon for the acetate group (OAc, δC 169.4) was positioned at C-1 due to a higher chemical shift value (δC 73.8) in the downfield region, compared with C-1 in compounds 2 and 3 (67.8 ppm). The compound 4 relative stereochemistry was assigned using the NOESY correlations of H3-18/H-6, H3-19/H-5, and H-5/H-3α (Fig. 2). Further evidence for the α-configuration of the C-1 acetoxy group was provided by NOESY cross-peaks among H-1, H-6β, and H2-20, which inferred their co-facial relationship. The location of C-13 was deduced from strong correlations connecting H-12β and H-14 to H3-17β, and the lack of correlation between H-11 and either H-14 or H-15 in the NOESY spectrum. Based on these considerations, 4 was characterized as 1α-acetoxy-13β-methyl-6,7-seco-7,20-olide-8,9-tricyclo[3.2.1.02,7]octane-isopimara-8-en-6-al.
The relative configuration of the carbon positions 5, 10, 11, 13, and 14 in 4 was determined by DP4 + NMR chemical shift probability analysis. 1H and 13C chemical shifts for four possible isomers (4 and 4a–4c) were computed and compared to the experimental values (see Additional file 1). The statistical analysis confirmed the agreement with isomer 4, with a 100% probability. Furthermore, the high resemblance between the calculated and measured ECD spectra of 4 established the (1S,5S,10S,11R,13R,14S,15S) absolute configuration (Fig. 4).
It is noteworthy that compound 4 is partially associated with trachylobane diterpenoids [13, 14], known for their characteristic cyclopropane moiety. However, 4 stands out from this structural family by incorporating two additional functional elements, which are the adjacent tricyclo[3.2.1.02,7]octene ring system [15, 16] and a spirocyclic lactone ring junction at C-10, thereby expanding the diversity of this particular structural type.
The putative biosynthetic pathway of compounds 1–4 is illustrated in Fig. 5. Compounds 1–4 are possibly formed from geranylgeranyl pyrophosphate (GGPP) through the pimara-8(14),15-diene (I). Oxidation at multiple sites of I gives intermediate II, which is presumably a common biosynthetic precursor of compounds 1–4. Further oxidation at C-6 of II followed by ketal formation gives IV, which is then acetylated at 7-OH to give 3. Alternatively, oxidation at C-7 of II followed by ketal formation provides intermediate VI. Acetylation at different sites of VI yields compounds 1 and 2 and intermediate VII. Compound 4 is proposed to originate from VII, whereby the glycol cleavage followed by dehydration generates the diene moiety in IX. Upon intramolecular Diels–Alder reaction with the adjacent double bond in IX, compound 4 is formed.
Kaemtakols A–D (1–4) were screened for their inhibitory activity in suppressing the NO production triggered by lipopolysaccharide in RAW 264.7 macrophage cells and the NF-κB production activated by cytokine-induced inflammation in HaCat human skin cells. The results (Table 2) showed that 2 potently inhibited NO production having an IC50 of 0.69 μM. In contrast, substituting the acetylated group at position 1 of compound 2, namely kaemtakol A (1), abolished anti-inflammation activity (IC50 = 103.9 μM). In addition, compounds 1–3 satisfyingly exhibited minimal cytotoxicity towards RAW 264.7 cells at the specific concentrations needed to inhibit NO production. Nevertheless, these compounds did not show discernible inhibitory effects against NF-κB (EC50 > 100 μM).
To determine the possible binding mode of compound 2 to iNOS, docking studies were conducted using the crystal structure with high-resolution iNOS protein (PDB 3E6T). Results (Fig. 6a, b) revealed that the binding position of 2 was next to cofactors: HEM-901 and H4B-902, and overlapped partly with that of the iNOS inhibitor AR-C118901 [17]. Compound 2 exhibited a binding energy of − 8.0 kcal/mol, which was marginally greater than that of AR-C118901 (− 9.2 kcal/mol), indicating that 2 and the cocrystal inhibitor had roughly equivalent binding affinities (Table S16). Moreover, 2 occupied the binding pocket through hydrophobic interactions and hydrogen bonds with crucial amino acid residues, including GLN257, ARG260, TYR341 and ARG260 (Fig. 6c). As depicted in Fig. 6d, the hydroxy and acetoxy groups of 2 played an important role in hydrogen contacts with GLN257 and ARG260, while its alkene and methyl groups took part in the hydrophobic interactions with MET114, TRP84, TYR341, and TYR367 in the cavity of iNOS.
3 Experimental procedures
3.1 General experimental procedures
Column gel filtration involved using Sephadex LH-20 (GE Healthcare) and MCI gel (75–150 μm; Mitsubishi Chemical, Tokyo), as well as RP-C18 and silica gel 60 from Merck for column chromatography separation. HPLC analysis was carried out using a Waters Delta 600 with a Waters 2996 photodiode array detector. NMR spectra were collected using Bruker Avance 400 and 600 spectrometers. HRESIMS analysis was performed with a Bruker Daltonics microTOF spectrometer. A PerkinElmer Spectrum One Spectrometer using a universal attenuated reflectance (ATR) technique was utilized to record the IR spectra. A JASCO P-1020 polarimeter was employed for recording optical rotation, and A JASCO J-810 spectropolarimeter for recording CD spectra.
3.2 Plant materials
In April 2022, the whole plants of Kaempferia takensis Boonma & Saensouk were collected in Tak Province, Thailand. Assist. Prof. Dr. Saroj Ruchisansakun provided the identification. The Suan Luang Rama IX Botanic Garden in Thailand housed a reference specimen (S.R. 1851).
3.3 Extraction and isolation
The fresh K. takensis rhizomes (414.6 g) were soaked in two rounds with an equal volume (1.5 L) of 95% EtOH and 50% dichloromethane-MeOH mixture at ambient temperature, respectively. The complete evaporation of the solvent gave respective crude extracts of 7.04 g and 1.53 g. Due to these two crude extracts exhibiting the same NMR patterns of diterpenoids, we decided to combine them to yield 8.6 g of a crude extract in order to get more pure active compounds.
The combined crude extract (8.6 g) was processed to the Sephadex LH-20 column using a dichloromethane-MeOH (1:1) elution, resulting in four fractions (F1–F4). F3 (2.8 g) was subjected to further separation on a Sephadex LH-20 column, and elution was carried out using a dichloromethane-MeOH (60:40) mixture to obtain four subfractions (Fr3.1–Fr3.4). Fr. 3.2 (289.4 mg) was purified using semi-preparative HPLC with a Hichrom C18 (250 × 21 mm i.d.). Elution was carried out with a gradient of 50:50–95:5 MeCN in H2O for 90 min at a flow rate of 10 mL/min, monitored at UV wavelength λ 220 nm. This process yielded 1.4 mg of kaemtakol D (4, tR 25 min). Fr. 3.3 (287.0 mg) underwent purification using preparative HPLC with a YMC-Pack ODS-A C18 column (250 × 20 mm i.d.). The purification was achieved through gradient elution with 50–95% MeCN in H2O for 45 min at a flow rate of 10 mL/min, monitored at a UV wavelength of λ 220 nm. This process yielded 28.0 mg of kaemtakol A (1, tR 16 min). Fr. 3.4 (2.3 g) was subjected to gel filtration with Sephadex LH20, using 100% MeOH as the eluent, resulting in the separation into six subfractions (Fr.3.4.1–3.4.6). Subsequently, Fr. 3.4.2 (2.0 g) underwent a second round of separation by Sephadex LH20, again using 100% MeOH as the eluent, yielding six additional subfractions (Fr.3.4.2.1–3.4.2.6). Fr. 3.4.2.3 (1.7 g) was additionally purified by semi-preparative HPLC (Hichrom C18 250 × 21 mm i.d.) with 50–95% MeCN in H2O gradient elution over 90 min at a flow rate of 10 mL/min, monitored at UV λ 220 nm. This process yielded kaemtakol B (2, 140.0 mg, tR 12 min) and kaemtakol C (3, 43.0 mg, tR 14 min).
3.3.1 Kaemtakol A (1)
Colorless crystals; C22H32O6, mp 205–208 °C; \({\left[\alpha \right]}_{\mathrm{D}}^{24}\) +40.6 (c 0.59, MeOH); UV (MeOH) λmax (log ε): 279 (0.838) and 212 (2.916) nm; CD (MeOH) λmax (∆ε) 222 (–87.9289) nm; IR (ATR) νmax 3415, 2953, 2869, 1740, 1608, 1372, 1227, 1026, 910, 829, and 733 cm–1; 1H (400 MHz) NMR data (CDCl3) and 13C (100 MHz) NMR data (CDCl3) see Table 1; ESI HRMS m/z 457.2204 [M + Na]+ (calcd for C24H34O7Na, 457.2197).
3.3.2 Kaemtakol B (2)
White amorphous; C22H32O6, \({\left[\alpha \right]}_{\mathrm{D}}^{25}\) +43.5 (c 0.15, MeOH); UV (MeOH) λmax (log ε) 245 (0.36) nm; CD (MeOH) λmax (∆ε) 343 (–11.6695), 255 (–14.299), 220 (–63.4363) nm; IR (ATR) νmax 3413, 2935, 1734, 1365, 1235, 1023, 911, 829, and 729 cm–1; 1H (400 MHz) NMR data (CDCl3) and 13C (100 MHz) NMR data (CDCl3) see Table 1; ESI HRMS m/z 415.2099 [M + Na]+ (calcd for C22H32O6Na, 415.2091).
3.3.3 Kaemtakol C (3)
White amorphous; C22H32O6, \({\left[\alpha \right]}_{\mathrm{D}}^{25}\) +43.1 (c 0.38, MeOH); UV (MeOH) λmax (log ε) 214 (0.30) nm; CD (MeOH) λmax (∆ε) 225 (–10.8958) nm, 215 (–15.1665) nm, 196 (+ 3.7076) nm; IR (ATR) νmax 3375, 2943, 1725, 1636, 1371, 1237, 1191, 1047, 960, 891, and 735 cm–1; 1H (400 MHz) NMR data (CDCl3) and 13C (100 MHz) NMR data (CDCl3) see Table 1; ESI HRMS m/z 415.2097 [M + Na]+ (calcd for C22H32O6Na, 415.2091).
3.3.4 Kaemtakol D (4)
White amorphous; C22H28O5, \({\left[\alpha \right]}_{\mathrm{D}}^{24}\) +182.1 (c 0.08, MeOH); CD (MeOH) λmax (∆ε) 264 (+ 13.7087) nm, 233 (+ 6.6737) nm; IR (ATR) νmax 3352, 2927, 2866, 1732, 1714, 1655, 1374, 1236, 1115, 1063, and 764 cm–1; 1H (400 MHz) NMR data (CDCl3) and 13C (100 MHz) NMR data (CDCl3) see Table 1; ESI HRMS m/z 395.1827 [M + Na]+ (calcd for C22H28O5Na, 395.1829).
3.4 X-ray crystallographic analysis of 1
Colorless crystals of kaemtakol A (1) were obtained using the vapor diffusion method from a solution of MeOH-EtOH (1:1) and MeOH. X-ray crystallographic analyses were conducted at 150 K using a Bruker APEX-II CCD diffractometer with Mo Kα radiation. The crystallographic data was submitted to the Cambridge Crystallographic Data Center (CCDC number 2247367). The data is accessible at no cost through www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 IEZ, UK, fax: + 44 1223 336,033.
3.5 ECD calculations and DP4 + analysis
The computation methods employed in this study were slightly modified from previous reports [18]. A conformational search within a 5 kcal/mol energy window was conducted using Spartan’ 20 with the MMFF94 molecular mechanics model. The Gaussian 16 Rev. C.01 package was utilized for DFT calculations [19, 20]. All low-energy conformers were additionally optimized at the ωB97XD/cc-PVDZ level of theory with the IEFPCM solvent model (methanol). At the same computational level, the vibrational frequencies of all optimized conformers were analyzed to verify the presence of actual electronic potential energy minima, and no imaginary frequency was detected. The low-Gibbs free energy conformer with over 2% population in the Boltzmann distribution was subjected to ECD calculations. TD-DFT calculations were performed at the M06-2x/def2-SVP level with the IEFPCM solvent model (methanol) [21,22,23]. For each conformer, calculations were performed for 30 excited states, and the simulated ECD curves were post-processed using SpecDis. This involved applying a Boltzmann averaging approach across all conformers and employing overlapping Gaussian functions with an exponential half-width (σ = 0.35) [24, 25]. The theoretical ECD spectra of 1–4 of their related diastereomers and enantiomers were directly compared with experimental ECD spectra. In addition, for the same set of low-energy conformers, magnetic shielding tensors (σ) were computed using the GIAO method at the mPW1PW91/6–31 + G(d,p) level in PCM solvent modeling, and then weight-averaged. Finally, DP4 + analysis was carried out using the provided Excel tool [26]. CYLview was utilized for virtualizing all 3D structures [27].
3.6 Molecular docking with human iNOS
Molecular docking was performed using Autodock Vina [28, 29] and AutoDockTool 1.5.6 to examine the binding of compound 2 in the cavity of iNOS oxygenase. The protein structure involved in the inhibition of nitric oxide synthase (NOS), iNOS oxygenase (PDB 3E6T), was acquired from Protein Data Bank (http://www.rcsb.org/). This structure served as the receptor. The molecular structure of 2 was obtained through geometry optimization using Gaussian09 at the B3LYP/6-311G* level. The central grid parameters were set at 70–70-70 along the x-, y- and z-axes, with a 1.000 Å spacing to encompass all protein structures. The analysis and visualization of the docking results were performed using the BIOVIA Discovery Studio Visualizer [30].
3.7 Inhibition of NO production in LPS-activated murine macrophages (RAW 264.7 cells)
The inhibitory assay followed the methods described previously with some modifications [31, 32]. RAW 264.7 cells were seeded at 3 × 104 cells/well in a 96-well flat bottom plate and cultured in DMEM high glucose supplemented with 10% FBS, 1% penicillin–streptomycin, and 1% HEPES. The plates were initially incubated at 37 °C for 24 h under 5% CO2 atmosphere. Thereafter, LPS (0.25 μg/mL) in the absence or presence of different concentrations of kaemtakols (100, 10, 1, 0.1, 0.01, and 0.001 μg/mL) were introduced into the culture plate and then incubated further for 24 h under the same condition. Aminoguanidine hydrochloride (iNOS inhibitor) was also added as a positive control. The nitrite accumulation in the media was determined by the Griess reaction. The 75 μL of each culture supernatant was mixed with an equivalent amount of Griess reagent and the resulting mixture was incubated at room temperature for additional 10 min. Then, the absorbance at 546 nm was measured using a multimode microplate reader (ENVISION). The cytotoxicity of kaemtakols against RAW 264.7 was determined by a standard MTT assay.
3.8 Assessment of inhibitory effects on NF-κB nuclear translocation in human skin HaCaT cells
The assay followed the methods described previously with some modifications [33, 34]. Human skin cells (HaCaT cells) were seeded at 5 × 104 cells/well in a 96-well black flat-bottom plate, using DMEM (Dulbecco’s Modified Eagle Medium) high glucose supplemented with 10% FBS and 1% penicillin–streptomycin. The plates were then incubated at 37 °C for 24 h under 5% CO2 atmosphere. Following the initial incubation, a range of concentrations (100, 50, 25, 12.5, 6.25, 3.125 μM) of kaemtakols were introduced to the cells, and a subsequent 1-h incubation at 37 °C with 5% CO2 was carried out. Afterward, a cytokine cocktail comprising TNF-α (10 ng/mL), IL-1β (10 ng/mL), and IL-6 (10 ng/mL), along with the same concentration range of kaemtakols, was introduced to the culture plates and incubated at 37 °C with 5% CO2 for additional 30 min. Thereafter, the treated cells were fixed with 100% methanol at -20 °C for 10 min. The fixed cells underwent triple washes with DPBS before being exposed to a blocking solution (3% BSA) at room temperature for 60 min. Subsequently, a primary antibody (anti-NF-κB), a Rabbit monoclonal antibody, was introduced into the culture plate at a 1:500 ratio in DPBS and incubated at 4 °C overnight. Afterward, the culture plate was washed with DPBS three times. A secondary antibody (Alexa Fluor 488-conjugated goat anti-rabbit IgG) at a 1:500 ratio in DPBS was added to the culture plate and incubated for 1 h at room temperature in the dark. Simultaneously, Hoechst (at a 1:1,000 ratio in DPBS) was also added to the culture plate. The translocation of NF-κB in cells treated with the cytokine cocktail and kaemtakols was subsequently detected using a high-content imaging system (Operetta). The cell viability was determined by Hoechst DNA staining (Operetta).
4 Conclusions
In summary, unprecedented highly oxidized pimarane diterpenoids named kaemtakols A–D (1–4) were isolated from K. takensis for the first time. This discovery adds to the diversity of structural types of natural diterpenoids. Kaemtakol B displayed the highest potency in NO production inhibition, signifying its potential as a lead compound for novel anti-inflammatory agent development.
Availability of data and materials
All data generated or analyzed during this study are included in this published article and its additional information files.
References
Singh A, Singh N, Singh S, Srivastav RP, Singh L, Verma PC, et al. The industrially important genus Kaempferia: an ethnopharmacological review. Front Pharmacol. 2023. https://doi.org/10.3389/fphar.2023.1099523.
Techaprasan J, Klinbunga S, Ngamriabsakul C, Jenjittikul T. Genetic variation of Kaempferia (Zingiberaceae) in Thailand based on chloroplast DNA (psbA-trnH and petA-psbJ) sequences. Genet Mol Res. 2010;9:1957–73. https://doi.org/10.4238/vol9-4gmr873.
Thongnest S, Mahidol C, Sutthivaiyakit S, Ruchirawat S. Oxygenated pimarane diterpenes from Kaempferia marginata. J Nat Prod. 2005;68:1632–6. https://doi.org/10.1021/np0501861.
Boonsombat J, Mahidol C, Chawengrum P, Reuk-Ngam N, Chimnoi N, Techasakul S, et al. Roscotanes and roscoranes: oxygenated abietane and pimarane diterpenoids from Kaempferia roscoeana. Phytochemistry. 2017;143:36–44. https://doi.org/10.1016/j.phytochem.2017.07.008.
Booranaseensuntorn P, Boonsombat J, Mahidol C, Reuk-Ngam N, Khlaychan P, Batsomboon P, et al. Diterpenoids and p-methoxycinnamic acid diol esters from Kaempferia saraburiensis Picheans. (Zingiberaceae): structural assignment of saraburol and their biological activities. Phytochemistry. 2022. https://doi.org/10.1016/j.phytochem.2022.113181.
Kongwaen P, Boonsombat J, Thongnest S, Ruchisansakun S, Mahidol C, Ruchirawat S. Cytotoxic isopimarane diterpenoids from Kaempferia koratensis rhizomes. Rev Bras Farmacogn. 2023;33:415–21. https://doi.org/10.1007/s43450-023-00359-w.
Chawengrum P, Boonsombat J, Mahidol C, Eurtivong C, Kittakoop P, Thongnest S, et al. Diterpenoids with aromatase inhibitory activity from the rhizomes of Kaempferia elegans. J Nat Prod. 2021;84:1738–47. https://doi.org/10.1021/acs.jnatprod.0c01292.
Chokchaisiri R, Chaichompoo W, Chunglok W, Cheenpracha S, Ganranoo L, Phutthawong N, et al. Isopimarane diterpenoids from the rhizomes of Kaempferia marginata and their potential anti-inflammatory activities. J Nat Prod. 2020;83:14–9. https://doi.org/10.1021/acs.jnatprod.
Chokchaisiri R, Thothaisong T, Chunglok W, Chulrik W, Yotnoi B, Chokchaisiri S, et al. Marginaols G-M, anti-inflammatory isopimarane diterpenoids, from the rhizomes of Kaempferia marginata. Phytochemistry. 2022;200: 113225. https://doi.org/10.1016/j.phytochem.2022.113225.
Win NN, Hardianti B, Ngwe H, Hayakawa Y, Morita H. Anti-inflammatory activities of isopimara-8(9), 15-diene diterpenoids and mode of action of kaempulchraols B-D from Kaempferia pulchra rhizomes. J Nat Med. 2020;74:487–94. https://doi.org/10.1007/s11418-020-01389-7.
Win NN, Hardianti B, Kasahara S, Ngwe H, Hayakawa Y, Morita H. Anti-inflammatory activities of isopimara-8(14),-15-diene diterpenoids and mode of action of kaempulchraols P and Q from Kaempferia pulchra rhizomes. Bioorg Med Chem Lett. 2020;30: 126841. https://doi.org/10.1016/j.bmcl.2019.126841.
Pretsch E, Seibl J, Clerc T, Biemann, K. editors. Tables of spectral data for structure determination of organic compounds. Berlin, Heidelberg: Springer Berlin Heidelberg; 1989, pp H190.
Fraga BM. The trachylobane diterpenes. Phytochem Anal. 1994;5:49–56. https://doi.org/10.1002/pca.2800050202.
Graikou K, Aligiannis N, Skaltsounis AL, Chinou I, Michel S, Tillequin F, et al. New diterpenes from Croton insularis. J Nat Prod. 2004;67:685–8. https://doi.org/10.1021/np030423p.
Pelletier SW, Mody NV, Djarmati Z, Lajsic SD. The structures of staphigine and staphirine. Two novel bisditerpene alkaloids from Delphinium staphisagria. J Org Chem. 1976;41:3042. https://doi.org/10.1021/jo00880a032.
Bohlmann F, Jakupovic J, Ahmed M, Grenz M, Suding H, Robinson H, et al. Germacranolides and diterpenes from Viguiera species. Phytochemistry. 1981;20:113–6. https://doi.org/10.1016/0031-9422(81)85228-4.
Garcin E, Arvai A, Rosenfeld R, Kroeger MD, Crane BR, Andersson G, et al. Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase. Nat Chem Biol. 2008;4:700–7. https://doi.org/10.1038/nchembio.115.
Kaweetripob W, Thongnest S, Boonsombat J, Batsomboon P, Salae AW, Prawat H, et al. Phukettosides A-E, mono- and bis-iridoid glycosides, from the leaves of Morinda umbellata L. Phytochemistry. 2023;216: 113890. https://doi.org/10.1016/j.phytochem.2023.113890.
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, et al. Gaussian 16, Revision C.01, Gaussian, Inc., Wallingford CT, 2016.
Dennington R, Keith Todd A, Millam John M. GaussView, Version 6.1. Semichem Inc., Shawnee Mission, KS, 2016.
Zhao Y, Truhlar DG. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals. Theor Chem Acc. 2008;120:215–41. https://doi.org/10.1007/s00214-007-0310-x.
Weigend F. Accurate coulomb-fitting basis sets for H to Rn. Phys Chem Chem Phys. 2006;8:1057–65. https://doi.org/10.1039/B515623H.
Weigend F, Ahlrichs R. Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: design and assessment of accuracy. Phys Chem Chem Phys. 2005;7:3297–305. https://doi.org/10.1039/B508541A.
Bruhn T, Schaumlöffel A, Hemberger Y, Bringmann G. SpecDis: quantifying the comparison of calculated and experimental electronic circular dichroism spectra. Chirality. 2013;25:243–9. https://doi.org/10.1002/chir.22138.
Bruhn T, Schaumlöffel A, Hemberger Y, Pescitelli G. SpecDis, ver. 1.71 Berlin, Germany, 2017, http:/specdis-software.jimdo.com.
Zanardi MM, Sarotti AM. Sensitivity analysis of DP4+ with the probability distribution terms: development of a universal and customizable method. J Org Chem. 2021;86:8544–8. https://doi.org/10.1021/acs.joc.1c00987.
CYLview20; Legault CY. Université de Sherbrooke. 2020. http://www.cylview.org.
Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model. 2021;61:3891–8. https://doi.org/10.1021/acs.jcim.1c00203.
Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–61. https://doi.org/10.1002/jcc.21334.
Biovia DS, Discovery studio visualizer. San Diego. 2019.
Cheenpracha S, Park EJ, Rostama B, Pezzuto JM, Chang LC. Inhibition of nitric oxide (NO) production in lipopolysaccharide (LPS)-activated murine macrophage RAW 264.7 cells by the norsesterterpene peroxide, epimuqubilin A. Mar Drugs. 2010;8:429–37. https://doi.org/10.3390/md8030429.
Min HY, Kim MS, Jang DS, Park EJ, Seo EK, Lee SK. Suppression of lipopolysaccharide-stimulated inducible nitric oxide synthase (iNOS) expression by a novel humulene derivative in macrophage cells. Int Immunopharmacol. 2009;9:844–9. https://doi.org/10.1016/j.intimp.2009.03.005.
Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, Miller AH, Pace TW. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol. 2012;12:368–77. https://doi.org/10.1016/j.intimp.2011.12.009.
Wongkrasant P, Pongkorpsakol P, Chitwattananont S, Satianrapapong W, Tuangkijkul N, Muanprasat C. Fructo-oligosaccharides alleviate inflammation-associated apoptosis of GLP-1 secreting L cells via inhibition of iNOS and cleaved caspase-3 expression. J Pharmacol Sci. 2020;143:65–73. https://doi.org/10.1016/j.jphs.2020.03.001.
Acknowledgements
S.T. expressed gratitude for the financial assistance provided by the Thailand Science Research and Innovation (TSRI), Chulabhorn Research Institute (Grant No. 36824/4274394 and 36827/4274406), and the Center of Excellence on Environmental Health and Toxicology (EHT), OPS, Ministry of Higher Education, Science, Research and Innovation. The authors acknowledge the involvement of C. Theppitak of Thammasat University in the single-crystal X-ray diffraction investigation. The authors also extend their thanks to P. Kanjanasirirat and K. Jearawuttanakul of the Excellent Center for Drug Discovery (ECDD), Mahidol University, for conducting anti-inflammation tests.
Funding
Thailand Science Research and Innovation, 36824/4274394, Sanit Thongnest, 36827/4274406, Sanit Thongnest.
Author information
Authors and Affiliations
Contributions
OJ isolation and purification of isolated compounds; JB project planning and coordination, data analysis, and manuscript preparation; ST project planning and coordination, conceptual and technical guidance, compound identification, data analysis, and manuscript preparation; HP compound identification; PB CD and DP4 + calculation; SC anti-inflammatory activity assessment; SRuchisansakul plant collection and identification; KC X-ray crystallography analysis; JS molecular docking study; CM and SRuchirawat project supervision. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This article does not contain any studies with human participants or animals performed by any of the authors.
Competing interests
The authors declare no conflict of interest associated with this.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1.
X-ray crystal data analyses and structure refinement for 1. Spectra of compounds 1–4, including 1D- and 2D-NMR, ESI HRMS, CD, ECD, and IR techniques. ECD calculations and DP4 + analysis. X-ray crystallographic data for compound 1. Table S1 DP4 + probability Excel sheets of compound 4. Table S2 Conformational analysis of 1. Table S3 Conformational analysis of 2. Table S4 Conformational analysis of 3. Table S5 Conformational analysis of 4. Table S6 Conformational analysis of 4a. Table S7 Conformational analysis of 4b. Table S8 Conformational analysis of 4c. Table S9 Coordinates of Compound 1. Table S10 Coordinates of Compound 2. Table S11 Coordinates of Compound 3. Table S12 Coordinates of Compound 4. Table S13 Coordinates of Compound 4a. Table S14 Coordinates of Compound 4b. Table S15 Coordinates of Compound 4c. Table S16 Summary of binding energies, amino acid residue involved in the hydrogen bond and hydrophobic interactions of 2 observed in molecular docking studies.. Figure S1 ORTEP drawing of crystal structure of 1. Figure S2 1H NMR spectrum (400 MHz) of compound 1 in CDCl3. Figure S3 13C NMR spectrum (100 MHz) of compound 1 in CDCl3. Figure S4 1H– 1H COSY spectrum of compound 1 in CDCl3. Figure S5 HSQC spectrum of compound 1 in CDCl3. Figure S6 HMBC spectrum of compound 1 in CDCl3. Figure S7 NOESY spectrum of compound 1 in CDCl3. Figure S8 HREI ( +) MS spectrum of compound 1. Figure S9 CD spectrum of compound 1. Figure S10 IR spectrum of compound 1. Figure S11 1H NMR spectrum (400 MHz) of compound 2 in CDCl3. Figure S12 13C NMR spectrum (100 MHz) of compound 2 in CDCl3. Figure S13 1H– 1H COSY spectrum of compound 2 in CDCl3. Figure S14 HSQC spectrum of compound 2 in CDCl3. Figure S15 HMBC spectrum of compound 2 in CDCl3. Figure S16 NOESY spectrum of compound 2 in CDCl3. Figure S17 HREI ( +) MS spectrum of compound 2. Figure S18 CD spectrum of compound 2. Figure S19 IR spectrum of compound 2. Figure S20 1H NMR spectrum (400 MHz) of compound 3 in CDCl3. Figure S21 13C NMR spectrum (100 MHz) of compound 3 in CDCl3. Figure S22 1H– 1H COSY spectrum of compound 3 in CDCl3. Figure S23 HSQC spectrum of compound 3 in CDCl3. Figure S24 HMBC spectrum of compound 3 in CDCl3. Figure S25 NOESY spectrum of compound 3 in CDCl3. Figure S26 HREI ( +) MS spectrum of compound 3. Figure S27 CD spectrum of compound 3. Figure S28 IR spectrum of compound 3. Figure S29 1H NMR spectrum (400 MHz) of compound 4 in CDCl3. Figure S30 13C NMR spectrum (100 MHz) of compound 4 in CDCl3. Figure S31 1H– 1H COSY spectrum of compound 4 in CDCl3. Figure S32 HSQC spectrum of compound 4 in CDCl3. Figure S33 HMBC spectrum of compound 4 in CDCl3. Figure S34 NOESY spectrum of compound 4 in CDCl3. Figure S35 HREI ( +) MS spectrum of compound 4. Figure S36 CD spectrum of compound 4. Figure S37 IR spectrum of compound 4.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jongsomjainuk, O., Boonsombat, J., Thongnest, S. et al. Kaemtakols A–D, highly oxidized pimarane diterpenoids with potent anti-inflammatory activity from Kaempferia takensis. Nat. Prod. Bioprospect. 13, 55 (2023). https://doi.org/10.1007/s13659-023-00420-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13659-023-00420-0